Hexal starts work on new pharmaceuticals plant in Warsaw for zl. 61 million

The Polish subsidiary of German pharmaceutical company Hexal has commenced construction of its own plant and drug wholesaler in Warsaw, which should be completed in 16 months. The value of the first phase of the investment is estimated at zl. 61 million. The construction has been on hold for over 2 years due to an unfavorable market situation for companies from this sector. "I hope the initiative will be welcomed by the Health, Finance and Economy Ministries. We are financing the investment from our own capital and bank loans, so this guarantees that the profits will not be transferred out of the country. Moreover, we will employ 200 people," said Hexal Polska president Andrzej Trzeciakowski. The new plant will produce drugs which have until now been imported from Hexal's German parent company. In the future Hexal plans to expand the plant and storage space, which will be worth zl. 45 million. (Puls Biznesu, pp. 1, 9) M.M.